Vonoprozan is a novel potassium-competitive acid blocker used for the treatment of acid related disorders
This novel recombinant has been developed and is a patented novel recombinant Human Albumin 20% process
Aptar Closures’ E-Disc Top securely protects against in-transit leakage while eliminating the need for liners and extra shipping preparation fees
A significant proportion of healthcare professionals still tend to favor branded drugs
The company will respond to the Warning Letter within the stipulated timelines
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
More than 10,000 scientific publications containing EUDRAGIT
Connecting new production and consumption areas of chilled food by low-carbon transportation services
This agreement paves the way for the introduction of YESAFILI into the Canadian market
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Subscribe To Our Newsletter & Stay Updated
